Back to Report Store Home

Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 – Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

  • Published: Nov-2018
  • Report Code: GBIHC485MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Atopic Dermatitis Therapeutics, South Korea, Age-Specific Prevalence (%), 2012 12

Figure 2: Prevalence of Atopic Dermatitis Associated Symptoms 13

Figure 3: Treatment Algorithm for Atopic Dermatitis Based on Severity 20

Figure 4: Atopic Dermatitis Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products for the Treatment of Atopic Dermatitis 32

Figure 5: Atopic Dermatitis Therapeutics Market, Global, Overview of Pipeline Products, 2018 35

Figure 6: Atopic Dermatitis Therapeutics Market, Global, Pipeline by Molecular Target, 2018 37

Figure 7: Atopic Dermatitis Therapeutics Market, Southeast Asia, Tralokinumab, Market Forecast ($m), 2021–2024 39

Figure 8: Atopic Dermatitis Therapeutics Market, Southeast Asia, Furestem-AD, Market Forecast ($m), 2021–2024 40

Figure 9: Atopic Dermatitis Therapeutics Market, Southeast Asia, Baricitinib, Market Forecast ($m), 2020–2024 42

Figure 10: Atopic Dermatitis Therapeutics Market, Comparative Efficacy and Safety Heatmap for Pipeline Products 45

Figure 11: Atopic Dermatitis Therapeutics Market, Competitor Matrix for AD Marketed and Pipeline Products 46

Figure 12: Atopic Dermatitis Therapeutics Market, Global, Average Clinical Trial Failure Rate (%), 2007–2018 48

Figure 13: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Failure Rates by Molecule Type (%), 2007–2018 49

Figure 14: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Failure Rates by Molecular Target (%), 2007–2018 50

Figure 15: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Trial by Molecule Type (participants), 2007–2018 51

Figure 16: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Trial by Molecular Target (participants), 2007–2018 52

Figure 17: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Product by Molecule Type (participants), 2007–2018 53

Figure 18: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Size per Product by Molecular Target (participants), 2007–2018 54

Figure 19: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecule Type (months), 2007–2018 55

Figure 20: Atopic Dermatitis Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecular Target (months), 2007–2018 56

Figure 21: Atopic Dermatitis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 56

Figure 22: Atopic Dermatitis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 57

Figure 23: Atopic Dermatitis Therapeutics Market, Southeast Asia, Treatment Usage Pattern (million), 2017–2024 59

Figure 24: Atopic Dermatitis Therapeutics Market, Southeast Asia, Market Size ($m), 2017–2024 60

Figure 25: Atopic Dermatitis Therapeutics Market, South Korea, Treatment Usage Patterns (million), 2017–2024 62

Figure 26: Atopic Dermatitis Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2017–2024 63

Figure 27: Atopic Dermatitis Therapeutics Market, South Korea, Market Size ($m), 2017–2024 64

Figure 28: Atopic Dermatitis Therapeutics Market, Singapore, Treatment Usage Patterns (million), 2017–2024 65

Figure 29: Atopic Dermatitis Therapeutics Market, Singapore, Annual Cost of Therapy ($), 2017–2024 66

Figure 30: Atopic Dermatitis Therapeutics Market, Singapore, Market Size ($m), 2017–2024 67

Figure 31: Atopic Dermatitis Therapeutics Market, Taiwan, Treatment Usage Patterns (million), 2017–2024 68

Figure 32: Atopic Dermatitis Therapeutics Market, Taiwan, Annual Cost of Therapy ($), 2017–2024 69

Figure 33: Atopic Dermatitis Therapeutics Market, Taiwan, Market Size ($m), 2017–2024 70

Figure 34: Atopic Dermatitis Therapeutics Market, Malaysia, Treatment Usage Patterns (million), 2017–2024 71

Figure 35: Atopic Dermatitis Therapeutics Market, Malaysia, Annual Cost of Therapy ($), 2017–2024 72

Figure 36: Atopic Dermatitis Therapeutics Market, Malaysia, Market Size ($m), 2017–2024 72

Figure 37: Atopic Dermatitis Therapeutics Market, Philippines, Treatment Usage Patterns (million), 2017–2024 73

Figure 38: Atopic Dermatitis Therapeutics Market, Philippines, Annual Cost of Therapy ($), 2017–2024 74

Figure 39: Atopic Dermatitis Therapeutics Market, Philippines, Market Size ($m), 2017–2024 75

Figure 40: Atopic Dermatitis Therapeutics Market, Thailand, Treatment Usage Patterns (million), 2017–2024 76

Figure 41: Atopic Dermatitis Therapeutics Market, Thailand, Annual Cost of Therapy ($), 2017–2024 77

Figure 42: Atopic Dermatitis Therapeutics Market, Thailand, Market Size ($m), 2017–2024 78

Figure 43: Atopic Dermatitis Therapeutics Market, Vietnam, Treatment Usage Patterns (million), 2017–2024 79

Figure 44: Atopic Dermatitis Therapeutics Market, Vietnam, Annual Cost of Therapy ($), 2017–2024 79

Figure 45: Atopic Dermatitis Therapeutics Market, Vietnam, Market Size ($m), 2017–2024 80

Figure 46: Atopic Dermatitis Therapeutics Market, Indonesia, Treatment Usage Patterns (million), 2017–2024 81

Figure 47: Atopic Dermatitis Therapeutics Market, Indonesia, Annual Cost of Therapy ($), 2017–2024 82

Figure 48: Atopic Dermatitis Therapeutics Market, Indonesia, Market Size ($m), 2017–2024 83

Figure 49:Atopic Dermatitis Therapeutics Market, Global, Licensing Deals by Region and Value, 2007–2018 86

Figure 50: Atopic Dermatitis Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2007–2018 87

Figure 51: Atopic Dermatitis Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2007–2018 88

Figure 52: Atopic Dermatitis Therapeutics, Global, Licensing Deals by Molecule Type and Stage of Development, 2007–2018 89

Figure 53: Atopic Dermatitis Therapeutics, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2007–2018 90

Figure 54:Atopic Dermatitis Therapeutics Market, Global, Co-development Deals by Region, 2007–2018 92

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards